Effect of alogliptin on diabetic vascular complication
Phase of Trial: Phase II
Latest Information Update: 13 Mar 2019
Price : $35 *
At a glance
- Drugs Alogliptin (Primary)
- Indications Atherosclerosis; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 11 Mar 2019 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 06 Jul 2013 New trial record